Reference
Bodiwala V, et al. Comparing efficacy and adverse effects of biological agents in South Asian inflammatory bowel disease patients living in the United States to Caucasian American patients. American Journal of Gastroenterology 114 (Suppl.): S472-S473 abstr. 819, Oct 2019. Available from: URL: http://doi.org/10.14309/01.ajg.0000592812.21840.b0 [abstract]
Rights and permissions
About this article
Cite this article
Adalimumab/infliximab. Reactions Weekly 1793, 22 (2020). https://doi.org/10.1007/s40278-020-75364-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-75364-y